Cookies

We use cookies to ensure that we give you the best experience on our website. You can change your cookie settings at any time. Otherwise, we'll assume you're OK to continue.


Durham Research Online
You are in:

Rational drug design - identifying and characterising a target.

Todd, A. and Anderson, R.J. and Groundwater, P.W. (2009) 'Rational drug design - identifying and characterising a target.', The pharmaceutical journal., 283 (7559). pp. 19-20.

Abstract

Structure-based drug design is now a common method used by the pharmaceutical industry to identify a lead compound and take it forward for further development. This article describes the methods used to identify and characterise a target for structured drug design and illustrates how pharmacists can play an important role in this process, under the headings: identifying a target; proteomics; the poptein databank; DNA; enzyme inhibitors; receptor agonists and antagonists; rational drug design.

Item Type:Article
Keywords:Drug Development, Structure-activity Relationship, Proteins, DNA, Enzyme Inhibitors, Review.
Full text:Full text not available from this repository.
Publisher Web site:http://www.pjonline.com/contents/pj20090704
Record Created:28 Jun 2012 11:20
Last Modified:05 Dec 2012 12:33

Social bookmarking: del.icio.usConnoteaBibSonomyCiteULikeFacebookTwitterExport: EndNote, Zotero | BibTex
Usage statisticsLook up in GoogleScholar | Find in a UK Library